Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | BRAF | P15056 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10192226 | 1.00 | KDM4E (0.41) | KDM4EATMHTTSIGMAR1DRD2 | |
| SCHEMBL7858958 | 0.98 | SIGMAR1 (0.41) | KDM4EATMHTTSIGMAR1DRD2 | |
| SCHEMBL22032186 | 0.90 | SIGMAR1 (0.44) | ATMSIGMAR1DRD2HTR2ATRPM8 | |
| SCHEMBL863351 | 0.83 | OPRD1 (0.44) | SIGMAR1DRD2HTR2ALMNACYP2D6 | |
| SCHEMBL3560241 | 0.82 | SIGMAR1 (0.57) | SIGMAR1DRD2HTR2ATRPM8MAOA | |
| SCHEMBL24203777 | 0.81 | SIGMAR1 (0.42) | ATMSIGMAR1DRD2HTR2ATRPM8 | |
| SCHEMBL231585 | 0.81 | OPRD1 (0.49) | SIGMAR1DRD2HTR2ALMNACYP2D6 | |
| SCHEMBL2743253 | 0.79 | KMT2A (0.49) | SIGMAR1DRD2HTR2ATRPM8KMT2A | |
| Hydrochloric Acid SCHEMBL10502202 | 0.79 | OPRD1 (0.48) | SIGMAR1DRD2HTR2ALMNACYP2D6 | |
| SCHEMBL8812382 | 0.79 | HTR2A (0.44) | SIGMAR1DRD2HTR2AALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102124-A1 | PREDICTION FUNNEL FOR GENERATION OF HYPO- AND HYPER-GLYCEMIC ALERTS BASED ON CONTINUOUS GLUCOSE MONITORING DATA | DEXCOM INC (US) | 2026-04-16 | — | — | US | disclosed |
| EP-4685813-A2 | PREDICTION FUNNEL FOR GENERATION OF HYPO- AND HYPER GLYCEMIC ALERTS BASED ON CONTINUOUS GLUCOSE MONITORING DATA | DexCom, Inc. (US) | 2026-01-28 | — | — | EP | disclosed |
| US-12400325-B2 | Lumbar spine anatomical annotation based on magnetic resonance images using artificial intelligence | THE UNIVERSITY OF HONG KONG (CN) | 2025-08-26 | — | — | US | disclosed |
| US-20250086794-A1 | METHOD AND SYSTEM FOR CALCULATING MYOCARDIAL INFARCTION LIKELIHOOD BASED ON LESION WALL SHEAR STRESS DESCRIPTORS | PIE MEDICAL IMAGING B V (NL) | 2025-03-13 | — | — | US | disclosed |
| US-12190504-B2 | Method and system for calculating myocardial infarction likelihood based on lesion wall shear stress descriptors | PIE MEDICAL IMAGING B.V. (NL) | 2025-01-07 | — | — | US | disclosed |
| EP-4247263-B1 | METHOD AND SYSTEM FOR CALCULATING MYOCARDIAL INFARCTION LIKELIHOOD BASED ON LESION WALL SHEAR STRESS DESCRIPTORS | PIE MEDICAL IMAGING BV (NL) | 2024-10-02 | — | — | EP | disclosed |
| CN-118679524-A | Predictive funnel for generating a hypoglycemic alarm and a hyperglycemic alarm based on continuous glucose monitoring data | 德克斯康公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-118660868-A | Calcium channel blockers and methods of screening | 解明岐 | 2024-09-17 | — | — | CN | disclosed |
| EP-4427234-A1 | PREDICTION FUNNEL FOR GENERATION OF HYPO- AND HYPER GLYCEMIC ALERTS BASED ON CONTINUOUS GLUCOSE MONITORING DATA | Dexcom, Inc. (US) | 2024-09-11 | — | — | EP | disclosed |
| CN-116568218-B | Method and system for calculating probability of myocardial infarction based on lesion wall shear stress descriptor | 帕伊医疗成像有限公司 | 2024-04-30 | — | — | CN | disclosed |
| EP-0560929-A4 | — | — | 1994-08-31 | — | — | EP | disclosed |
| EP-0561989-A4 | — | — | 1994-03-09 | — | — | EP | disclosed |
| EP-0561989-A1 | COMPOUNDS THAT INHIBIT COMPLEMENT AND/OR SUPPRESS IMMUNE ACTIVITY | T CELL SCIENCES, INC. (US) | 1993-09-29 | — | — | EP | disclosed |
| EP-0560929-A1 | SYNERGISTIC COMPOSITIONS OF SOLUBLE COMPLEMENT RECEPTORS AND COMPOUNDS THAT INHIBIT COMPLEMENT AND/OR SUPPRESS IMMUNE ACTIVITY | T CELL SCIENCES, INC. (US) | 1993-09-22 | — | — | EP | disclosed |
| WO-1992010096-A1 | COMPOUNDS THAT INHIBIT COMPLEMENT AND/OR SUPPRESS IMMUNE ACTIVITY | T CELL SCIENCES, INC. (US) | 1992-06-25 | — | — | WO | disclosed |
| WO-1992010205-A1 | SYNERGISTIC COMPOSITIONS OF SOLUBLE COMPLEMENT RECEPTORS AND COMPOUNDS THAT INHIBIT COMPLEMENT AND/OR SUPPRESS IMMUNE ACTIVITY | T CELL SCIENCES, INC. (US) | 1992-06-25 | — | — | WO | disclosed |
| WO-1991016888-A1 | SPIRO[BENZOFURANCYCLOALKANE]CARBOXAMIDES AS 5HT3 ANTAGONISTS | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS), INC. (US) | 1991-11-14 | — | — | WO | disclosed |
| US-4910323-A | Chlorination using n-chlorosuccinimide | HOECHST ROUSSEL PHARMACEUTICALS, INC. (US) | 1990-03-20 | — | — | US | disclosed |
| US-4847414-A | INTERMEDIATES FOR ANTIDEPRESSANTS, ANALGESICS | HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) | 1989-07-11 | — | — | US | disclosed |
| US-4404221-A | ANALGESICS AND ATNIDEPRESSANTS | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1983-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102124-A1 | PREDICTION FUNNEL FOR GENERATION OF HYPO- AND HYPER-GLYCEMIC ALERTS BASED ON CONTINUOUS GLUCOSE MONITORING DATA | SLC2A8, SLC2A4, SLC5A2 | KDM4E 4505/4885ATM 1956/4885HTT 2595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.